Conference item icon

Conference item : Abstract

Safety and Clinical Activity of Mutant IDH1 Inhibitor IVOSIDENIB (IVO; AG-120) In Combination with AZACITIDINE (AZA) for Newly Diagnosed Acute Myeloid Leukemia (ND AML)

Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1007/s00277-019-03619-9

Authors


Publisher:
Springer
Host title:
Annals of Hematology
Journal:
Annals of Hematology More from this journal
Volume:
98
Issue:
S1
Pages:
S40-S41
Publication date:
2019-02-12
DOI:
EISSN:
1432-0584
ISSN:
0939-5555
Keywords:
Subtype:
Abstract
Pubs id:
pubs:981072
UUID:
uuid:68b7d4ad-7c97-4ca3-a933-7b70cfd37241
Local pid:
pubs:981072
Source identifiers:
981072
Deposit date:
2019-04-04

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP